Expert consensus on practical aspects in the treatment of chronic urticaria

by admin | May 31, 2021

Background Chronic urticaria (CU) is a common disease which represents a considerable burden formany patients. The current urticaria guideline describes the evidence-based diagnosis and treatment of CU. In addition, however, questions often arise in everyday practice...

H1-antihistamines and urticaria: how can we predict the best drug for our patient?

by mm-red | Jun 26, 2020

Urticaria, and especially chronic spontaneous urticaria (CSU), is a difficult condition to treat. Consequently, clinicians need to use the best H1-antihistamines currently available and the pharmaceutical industries need to keep developing H1-antihistamines that are...

H1-Antihistamines and itch in atopic dermatitis

by mm-red | Jun 23, 2020

Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion

by mm-red | Jun 23, 2020

   

The inhibition by levocetirizine and fexofenadine of the histamine-induced wheal and flare response in healthy Caucasian and Japanese volunteers

by mm-red | Jun 5, 2020

This randomized, double-blind, placebo-controlled cross- over study compared inhibition by one 5 mg dose of levocetirizine with two 60 mg doses of fexofenadine se- parated by 12 h of histamine-induced wheal and are responses in 9 Caucasian and 9 Japanese healthy male...